Y-mAbs Therapeutics
Mission:
Y-mAbs is a biopharmaceutical company focused on developing and commercializing novel, antibody-based therapeutic products to treat cancers.
Website:
Phone:
646-885-8505
Email:
Director:
Sue Smith
Y-mAbs Therapeutics
Categories
- Blog Posts (77)
- Guest Blogs (17)
- Member Blogs (30)
- Survivorship Matters Blog (9)
- CAC2 News (25)
- Collaborative Achievements (13)
- Community News (218)
- News Digest (173)
- Research Explained (10)
- Webinars (64)
Tags
#CancelChildhoodCancer (2)
Advocacy (51)
Annual Summit (7)
Appropriations (1)
Awareness (23)
AYA (2)
Best Practices (12)
Biorepositories (2)
CAC2 News (8)
CAC2 Project Incubator (1)
CAC2 Projects (11)
Call to Action (25)
Cancer Moonshot (1)
Clinical Trials (10)
COG (2)
Collaboration (12)
Comparative Oncology (1)
Data (15)
Delayed Diagnosis (2)
Digest (12)
Drug Development (12)
Drug Shortages (2)
Ethics (1)
Family Support (16)
FDA (1)
Funding Research (6)
Genomics (6)
Industry Perspective (5)
Member Access (12)
NCI (3)
Nutrition (2)
Patient-Reported Outcomes (1)
Prevention (5)
Psychosocial Support (6)
Rare and Ultra Rare Cancer (1)
Rare Cancers (1)
Regulations (3)
Research (38)
Research Advocacy (1)
Survivorship (27)
Venture Philanthropy (3)